We are live on ! Find out more
RCI

Ridgeback Capital Investments Portfolio holdings

AUM $560K
This Fund
S&P 500
This Quarter Est. Return
-44.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$37M
AUM Growth
–
Cap. Flow
+$44.4M
Cap. Flow %
120.01%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$44.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
1
Karyopharm Therapeutics
KPTI
$159M
$37M 100%
+263,013
New +$44.4M

Similar funds

LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
ZIMP
Zimmermann Investment Management & Planning New Cumberland, Pennsylvania $2.27M AUM 29.81% 1-Year Est. Return
XS
XR Securities Chicago, Illinois $5.35M AUM 26.1% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Ridgeback Capital Investments's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Ridgeback Capital Investments, which disclosed 1 position worth $37M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Karyopharm Therapeutics: 263,013 shares worth $37M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ridgeback Capital Investments's largest Q4 2018 buy was Karyopharm Therapeutics: 263,013 shares worth $37M.
  • Ridgeback Capital Investments's ten largest holdings make up 100% of its $37M portfolio in Q4 2018.
  • Ridgeback Capital Investments disclosed 1 position in Q4 2018, its first 13F filing on record.

Based on Ridgeback Capital Investments's 13F filing for Q4 2018, filed 14 Feb 2019.